GLP-1 Weight Loss Drugs Show Major Results But Raise Safety Questions
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
24 articles in this topic
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
Scientists discover how thin mountain air transforms red blood cells into glucose absorbers, explaining lower diabetes rates at elevation.
Reducing methionine and cysteine in diet activated calorie-burning beige fat as effectively as cold exposure, offering new weight loss insights.
New AI-powered blood test analyzes DNA fragments to catch liver fibrosis and cirrhosis in early, treatable stages before damage becomes irreversible.
Yale researchers solved how coenzyme A from vitamin B5 enters mitochondria, unlocking new insights into metabolism and disease prevention.
New research shows diabetes and weight-loss medications slow alcohol absorption, making people feel less intoxicated and potentially reducing drinking.
Yale study shows mindfulness training for stressed parents reduced childhood obesity risk more effectively than nutrition education alone.
New research shows ketogenic diet helps normalize blood sugar and dramatically improves muscle response to exercise in mice.
New research shows extreme calorie restriction alone matches bariatric surgery's diabetes reversal benefits without surgical risks.
New research exposes hidden psychological costs of weight loss surgery, including increased suicide risk and lasting mental health challenges.
New rare sugar sweetener may reduce body fat and blood sugar, but research shows mixed results and potential digestive issues.
Historical and modern evidence suggests fasting can reverse diabetes, but sustainable dietary changes are crucial for lasting results.